Review



autologous bm-mscs lenzumestrocel neuronata-r® inj  (Corestem Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Corestem Inc autologous bm-mscs lenzumestrocel neuronata-r® inj
    Summary of major MSC clinical trials for ALS.
    Autologous Bm Mscs Lenzumestrocel Neuronata R® Inj, supplied by Corestem Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/autologous bm-mscs lenzumestrocel neuronata-r® inj/product/Corestem Inc
    Average 90 stars, based on 1 article reviews
    autologous bm-mscs lenzumestrocel neuronata-r® inj - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Optimal Therapeutic Strategy of Bone Marrow-Originated Autologous Mesenchymal Stromal/Stem Cells for ALS"

    Article Title: Optimal Therapeutic Strategy of Bone Marrow-Originated Autologous Mesenchymal Stromal/Stem Cells for ALS

    Journal: Stem Cells Translational Medicine

    doi: 10.1093/stcltm/szad095

    Summary of major MSC clinical trials for ALS.
    Figure Legend Snippet: Summary of major MSC clinical trials for ALS.

    Techniques Used: Clinical Proteomics, Injection, Control



    Similar Products

    90
    Corestem Inc autologous bm-mscs lenzumestrocel neuronata-r® inj
    Summary of major MSC clinical trials for ALS.
    Autologous Bm Mscs Lenzumestrocel Neuronata R® Inj, supplied by Corestem Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/autologous bm-mscs lenzumestrocel neuronata-r® inj/product/Corestem Inc
    Average 90 stars, based on 1 article reviews
    autologous bm-mscs lenzumestrocel neuronata-r® inj - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Corestem Inc autologous bm-mscs (lenzumestrocel, neuronata-r® inj)
    Summary of major MSC clinical trials for ALS.
    Autologous Bm Mscs (Lenzumestrocel, Neuronata R® Inj), supplied by Corestem Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/autologous bm-mscs (lenzumestrocel, neuronata-r® inj)/product/Corestem Inc
    Average 90 stars, based on 1 article reviews
    autologous bm-mscs (lenzumestrocel, neuronata-r® inj) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Corestem Inc autologous bm msc lenzumestrocel (neuronata-r inj)
    Clinical trials listed on clinicaltrials.gov for amyotrophic lateral sclerosis
    Autologous Bm Msc Lenzumestrocel (Neuronata R Inj), supplied by Corestem Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/autologous bm msc lenzumestrocel (neuronata-r inj)/product/Corestem Inc
    Average 90 stars, based on 1 article reviews
    autologous bm msc lenzumestrocel (neuronata-r inj) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Corestem Inc lenzumestrocel (neuronata-r ® inj)
    Clinical trials using mesenchymal stem/stromal cells in amyotrophic lateral sclerosis.
    Lenzumestrocel (Neuronata R ® Inj), supplied by Corestem Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lenzumestrocel (neuronata-r ® inj)/product/Corestem Inc
    Average 90 stars, based on 1 article reviews
    lenzumestrocel (neuronata-r ® inj) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Summary of major MSC clinical trials for ALS.

    Journal: Stem Cells Translational Medicine

    Article Title: Optimal Therapeutic Strategy of Bone Marrow-Originated Autologous Mesenchymal Stromal/Stem Cells for ALS

    doi: 10.1093/stcltm/szad095

    Figure Lengend Snippet: Summary of major MSC clinical trials for ALS.

    Article Snippet: NCT01363401 , Korea/Corestem , Phase I , Two injections with a 26-day interval ( n = 7) , Autologous BM-MSCs (Lenzumestrocel, Neuronata-R® Inj) , Intrathecal , Safe , Oh et al. .

    Techniques: Clinical Proteomics, Injection, Control

    Summary of major MSC clinical trials for ALS.

    Journal: Stem Cells Translational Medicine

    Article Title: Optimal Therapeutic Strategy of Bone Marrow-Originated Autologous Mesenchymal Stromal/Stem Cells for ALS

    doi: 10.1093/stcltm/szad095

    Figure Lengend Snippet: Summary of major MSC clinical trials for ALS.

    Article Snippet: NCT01363401 , Korea/Corestem , Phase II, RCT without a sham procedure , Randomized (1:1) (i) Two injections with a 26-day interval ( n = 32) (ii) Control group ( n = 27) , Autologous BM-MSCs (Lenzumestrocel, Neuronata-R® Inj) , Intrathecal , Safe; positive clinical effect, reduced pro-inflammatory cytokines , Oh et al. .

    Techniques: Clinical Proteomics, Injection, Control

    Clinical trials listed on clinicaltrials.gov for amyotrophic lateral sclerosis

    Journal: Stem Cells Translational Medicine

    Article Title: Neural Cells for Neurodegenerative Diseases in Clinical Trials

    doi: 10.1093/stcltm/szad041

    Figure Lengend Snippet: Clinical trials listed on clinicaltrials.gov for amyotrophic lateral sclerosis

    Article Snippet: 13 , ALS , Corestem , Autologous BM MSC [Lenzumestrocel (Neuronata-R Inj.)] , IT , 2 M/kg or 5 M/kg , 115 , 2021 , 3 , NCT04745299.

    Techniques: Clinical Proteomics, Expressing, Transplantation Assay, Injection

    Clinical trials using mesenchymal stem/stromal cells in amyotrophic lateral sclerosis.

    Journal: Frontiers in Molecular Neuroscience

    Article Title: Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases

    doi: 10.3389/fnmol.2022.883378

    Figure Lengend Snippet: Clinical trials using mesenchymal stem/stromal cells in amyotrophic lateral sclerosis.

    Article Snippet: This is Lenzumestrocel (Neuronata-R ® Inj), produced by Corestem Inc., a SouthKorean biotech company.

    Techniques: Clinical Proteomics